These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38458195)

  • 1. CD8
    Aoki H; Kitabatake M; Abe H; Xu P; Tsunoda M; Shichino S; Hara A; Ouji-Sageshima N; Motozono C; Ito T; Matsushima K; Ueha S
    Cell Rep; 2024 Mar; 43(3):113887. PubMed ID: 38458195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8
    Ford ES; Mayer-Blackwell K; Jing L; Sholukh AM; St Germain R; Bossard EL; Xie H; Pulliam TH; Jani S; Selke S; Burrow CJ; McClurkan CL; Wald A; Holbrook MR; Eaton B; Eudy E; Murphy M; Postnikova E; Robins HS; Elyanow R; Gittelman RM; Ecsedi M; Wilcox E; Chapuis AG; Fiore-Gartland A; Koelle DM
    Res Sq; 2022 Oct; ():. PubMed ID: 36263073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccination.
    Nogimori T; Suzuki K; Masuta Y; Washizaki A; Yagoto M; Ikeda M; Katayama Y; Kanda H; Takada M; Minami S; Kobayashi T; Takahama S; Yoshioka Y; Yamamoto T
    Front Immunol; 2022; 13():1081047. PubMed ID: 36685601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA vaccination boosts S-specific T cell memory and promotes expansion of CD45RA
    Mayer-Blackwell K; Ryu H; Codd AS; Parks KR; MacMillan HR; Cohen KW; Stewart TL; Seese A; Lemos MP; De Rosa SC; Czartoski JL; Moodie Z; Nguyen LT; McGuire DJ; Ahmed R; Fiore-Gartland A; McElrath MJ; Newell EW
    Cell Rep Med; 2023 Aug; 4(8):101149. PubMed ID: 37552991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.
    Mok CKP; Chen C; Zhao S; Sun Y; Yiu K; Chan TO; Lai HL; Lai KC; Lau KM; Ling KC; Chan KKP; Ng SS; Ko FW; Peiris M; Hui DS
    Lancet Microbe; 2023 Jun; 4(6):e418-e430. PubMed ID: 37086735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2-specific CD8
    Rowntree LC; Petersen J; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Wheatley AK; Kent SJ; Rossjohn J; Kedzierska K; Nguyen TH
    Immunol Cell Biol; 2021 Oct; 99(9):990-1000. PubMed ID: 34086357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term memory CD8
    Kuse N; Zhang Y; Chikata T; Nguyen HT; Oka S; Gatanaga H; Takiguchi M
    Nat Commun; 2022 Sep; 13(1):5251. PubMed ID: 36068240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8
    Hernandez SPA; Hersby DS; Munk KK; Tamhane T; Trubach D; Tagliamonte M; Buonaguro L; Gang AO; Hadrup SR; Saini SK
    Front Immunol; 2022; 13():1035344. PubMed ID: 36703960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal structure and the specificity of vaccine-induced T cell response to SARS-CoV-2 Spike protein.
    Sheetikov SA; Khmelevskaya AA; Zornikova KV; Zvyagin IV; Shomuradova AS; Serdyuk YV; Shakirova NT; Peshkova IO; Titov A; Romaniuk DS; Shagina IA; Chudakov DM; Kiryukhin DO; Shcherbakova OV; Khamaganova EG; Dzutseva V; Afanasiev A; Bogolyubova AV; Efimov GA
    Front Immunol; 2024; 15():1369436. PubMed ID: 38629062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination.
    Riise J; Meyer S; Blaas I; Chopra A; Tran TT; Delic-Sarac M; Hestdalen ML; Brodin E; Rustad EH; Dai KZ; Vaage JT; Nissen-Meyer LSH; Sund F; Wader KF; Bjornevik AT; Meyer PA; Nygaard GO; König M; Smeland S; Lund-Johansen F; Olweus J; Kolstad A
    Br J Haematol; 2022 Jun; 197(6):697-708. PubMed ID: 35254660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose.
    Belik M; Liedes O; Vara S; Haveri A; Pöysti S; Kolehmainen P; Maljanen S; Huttunen M; Reinholm A; Lundberg R; Skön M; Österlund P; Melin M; Hänninen A; Hurme A; Ivaska L; Tähtinen PA; Lempainen J; Kakkola L; Jalkanen P; Julkunen I
    Front Immunol; 2023; 14():1099246. PubMed ID: 36756112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection.
    Dykema AG; Zhang B; Woldemeskel BA; Garliss CC; Rashid R; Westlake T; Zhang L; Zhang J; Cheung LS; Caushi JX; Pardoll DM; Cox AL; Ji H; Smith KN; Blankson JN
    EBioMedicine; 2022 Jun; 80():104048. PubMed ID: 35533495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable CD8
    Tranter E; Frentsch M; Hütter-Krönke ML; Vuong GL; Busch D; Loyal L; Henze L; Rosnev S; Blau IW; Thiel A; Beule D; Bullinger L; Obermayer B; Na IK
    J Med Virol; 2024 Mar; 96(3):e29539. PubMed ID: 38516755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered.
    López-Cortés LF; Saborido-Alconchel A; Trujillo-Rodríguez M; Serna-Gallego A; Llaves-Flores S; Muñoz-Muela E; Pérez-Santos MJ; Lozano C; Mejias-Trueba M; Roca C; Espinosa N; Gutiérrez-Valencia A
    Front Immunol; 2023; 14():1129753. PubMed ID: 37006309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid induction of antigen-specific CD4
    Painter MM; Mathew D; Goel RR; Apostolidis SA; Pattekar A; Kuthuru O; Baxter AE; Herati RS; Oldridge DA; Gouma S; Hicks P; Dysinger S; Lundgreen KA; Kuri-Cervantes L; Adamski S; Hicks A; Korte S; Giles JR; Weirick ME; McAllister CM; Dougherty J; Long S; D'Andrea K; Hamilton JT; Betts MR; Bates P; Hensley SE; Grifoni A; Weiskopf D; Sette A; Greenplate AR; Wherry EJ
    Immunity; 2021 Sep; 54(9):2133-2142.e3. PubMed ID: 34453880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominantly defective CD8
    Taus E; Shino MY; Ibarrondo FJ; Hausner MA; Hofmann C; Yang OO
    J Transl Med; 2023 Jun; 21(1):374. PubMed ID: 37291575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients.
    GeurtsvanKessel CH; Geers D; Schmitz KS; Mykytyn AZ; Lamers MM; Bogers S; Scherbeijn S; Gommers L; Sablerolles RSG; Nieuwkoop NN; Rijsbergen LC; van Dijk LLA; de Wilde J; Alblas K; Breugem TI; Rijnders BJA; de Jager H; Weiskopf D; van der Kuy PHM; Sette A; Koopmans MPG; Grifoni A; Haagmans BL; de Vries RD
    Sci Immunol; 2022 Mar; 7(69):eabo2202. PubMed ID: 35113647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron.
    Tarke A; Coelho CH; Zhang Z; Dan JM; Yu ED; Methot N; Bloom NI; Goodwin B; Phillips E; Mallal S; Sidney J; Filaci G; Weiskopf D; da Silva Antunes R; Crotty S; Grifoni A; Sette A
    Cell; 2022 Mar; 185(5):847-859.e11. PubMed ID: 35139340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8
    Minervina AA; Pogorelyy MV; Kirk AM; Crawford JC; Allen EK; Chou CH; Mettelman RC; Allison KJ; Lin CY; Brice DC; Zhu X; Vegesana K; Wu G; Trivedi S; Kottapalli P; Darnell D; McNeely S; Olsen SR; Schultz-Cherry S; Estepp JH; ; McGargill MA; Wolf J; Thomas PG
    Nat Immunol; 2022 May; 23(5):781-790. PubMed ID: 35383307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.